Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
International Journal of Experimental Pathology|February 10, 2009
Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c miceMark S Lever, Michelle Nelson, Anthony J Stagg, et al.International Journal of Antimicrobial Agents|April 20, 2006
Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacinJ Steward, T Piercy, M S Lever, et al.Scottish Medical Journal|August 4, 2012
Rationalized assessment of prolonged jaundice is safe and cost-effectiveM E Rodie, C Harry, R Taylor, et al.Journal of Human Hypertension|January 1, 1996
Prostacyclin biosynthesis in essential hypertension before and during treatmentJ M Ritter, S E Brett, J D Woods, et al.The Journal of Antimicrobial Chemotherapy|May 28, 2004
Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolonesJ Steward, M S Lever, A J H Simpson, et al.Kidney International|June 3, 1999
Clinical and biochemical correlates of starting "daily" hemodialysisJ D Woods, F K Port, S Orzol, et al.The Journal of Antimicrobial Chemotherapy|February 26, 2005
Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infectionJ Steward, T Piercy, M S Lever, et al.Antimicrobial Agents and Chemotherapy|July 14, 2010
Bioavailability and efficacy of levofloxacin against Francisella tularensis in the common marmoset (Callithrix jacchus)Michelle Nelson, Mark S Lever, Rachel E Dean, et al.JAMA|October 23, 1996
Predictors of type of vascular access in hemodialysis patientsR A Hirth, M N Turenne, J D Woods, et al.Harvard Business Review|June 7, 1993
Is this the right time to come out? Case studyA D Williamson, J D Woods, J M Conley, et al.Pageof 8